T. Heinze et al., MAMMARY SERUM ANTIGEN (MSA), CA-549, CA-15-3 AND CEA IN BREAST-CANCERPREOPERATIVE SENSITIVITY AND CORRELATION TO PROGNOSTIC FACTORS, Anticancer research, 17(4B), 1997, pp. 2953-2954
previously a higher preoperative sensitivity of the mucin like glycopr
otein Mammary Serum Antigen (MSA) compared to established tumor marker
s was reported. The aim of our study was the comparison of MSA and CA
549, CA 15-3 and CEA in primary breast cancer and the correlation to p
rognostic factors. In 119 patients MSA and CA 549 serum levels were an
alysed by ELISA, CEA and CA 15-3 levels by LIA. We received the follow
ing sensitivities: 30.2% for MSA (cut off = 55 U/mL), 21.8% for CA 549
(cut off = 12.6 U/mL), 20.5% for CA 15-3 (cut off = 25 U/ml) and 10.7
% for CEA (cut off = 6 ng/ml). Significant correlations were found bet
ween MSA concentrations and grading (p = 0.006), tumor size (p = 0.005
) and metastases (p = 0.03). No correlations were found to tumor type
hormone receptors, lymph node status and cathepsin D. MSA is a valuabl
e tumor marker with the highest preoperative sensitivity. Further stud
ies on the value of MSA in the follow-up are necessary.